Trade groups on bird flu
This article was originally published in The Tan Sheet
Executive Summary
"Marketers and retailers of dietary supplements are urged to refuse to stock or sell any products that are presented as preventing, treating or curing avian flu," a coalition of supplement industry trade groups announces in a joint advisory issued Nov. 18. The American Herbal Products Association, Consumer Healthcare Products Association, Council for Responsible Nutrition and National Nutritional Foods Association "encourag[e] consumers to use caution should they encounter products which claim to treat or prevent the avian flu" and note that "federal law and regulations do not allow any dietary supplement product" to make such claims. Although supplements can enhance general immune function, therapies for prevention or treatment of avian flu "should only be recommended by qualified healthcare professionals or public health authorities," the groups conclude...
You may also be interested in...
“Fowl” Play? FDA Warning Letters Target Avian Flu Supplement Marketers
Nine dietary supplement firms who received FDA warning letters for marketing their products as treatments for avian flu could face "far more serious enforcement activity" if they do not take "immediate corrective action," according to an industry lawyer
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.